Literature DB >> 32511001

Advancing Research on the Complex Interrelations Between Atrial Fibrillation and Heart Failure: A Report From a US National Heart, Lung, and Blood Institute Virtual Workshop.

Sana M Al-Khatib1, Emelia J Benjamin2, Christine M Albert3, Alvaro Alonso4, Cynthia Chauhan5, Peng-Sheng Chen6, Anne B Curtis7, Patrice Desvigne-Nickens8, Jennifer E Ho9, Carolyn S P Lam10, Mark S Link11, Kristen K Patton12, Margaret M Redfield13, Michiel Rienstra14, Yves Rosenberg8, Renate Schnabel15, John A Spertus16, Lynne Warner Stevenson17, Mellanie True Hills18, Adriaan A Voors14, Lawton S Cooper8, Alan S Go19,20,21.   

Abstract

The interrelationships between atrial fibrillation (AF) and heart failure (HF) are complex and poorly understood, yet the number of patients with AF and HF continues to increase worldwide. Thus, there is a need for initiatives that prioritize research on the intersection between AF and HF. This article summarizes the proceedings of a virtual workshop convened by the US National Heart, Lung, and Blood Institute to identify important research opportunities in AF and HF. Key knowledge gaps were reviewed and research priorities were proposed for characterizing the pathophysiological overlap and deleterious interactions between AF and HF; preventing HF in people with AF; preventing AF in individuals with HF; and addressing symptom burden and health status outcomes in AF and HF. These research priorities will hopefully help inform, encourage, and stimulate innovative, cost-efficient, and transformative studies to enhance the outcomes of patients with AF and HF.

Entities:  

Keywords:  atrial fibrillation; heart failure; research

Mesh:

Year:  2020        PMID: 32511001      PMCID: PMC7291844          DOI: 10.1161/CIRCULATIONAHA.119.045204

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  74 in total

1.  Augmented single-unit muscle sympathetic nerve activity in heart failure with chronic atrial fibrillation.

Authors:  Tatsunori Ikeda; Hisayoshi Murai; Shuichi Kaneko; Soichiro Usui; Daisuke Kobayashi; Manabu Nakano; Keiko Ikeda; Shin-Ichiro Takashima; Takeshi Kato; Masaki Okajima; Hiroshi Furusho; Masayuki Takamura
Journal:  J Physiol       Date:  2011-12-05       Impact factor: 5.182

Review 2.  Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications.

Authors:  Takatoshi Kasai; T Douglas Bradley
Journal:  J Am Coll Cardiol       Date:  2011-01-11       Impact factor: 24.094

Review 3.  Artificial Intelligence in Cardiology.

Authors:  Kipp W Johnson; Jessica Torres Soto; Benjamin S Glicksberg; Khader Shameer; Riccardo Miotto; Mohsin Ali; Euan Ashley; Joel T Dudley
Journal:  J Am Coll Cardiol       Date:  2018-06-12       Impact factor: 24.094

4.  Monitoring clinical changes in patients with heart failure: a comparison of methods.

Authors:  John Spertus; Eric Peterson; Mark W Conard; Paul A Heidenreich; Harlan M Krumholz; Philip Jones; Peter A McCullough; Ileana Pina; Joseph Tooley; William S Weintraub; John S Rumsfeld
Journal:  Am Heart J       Date:  2005-10       Impact factor: 4.749

5.  Modifiable Risk Factors for Incident Heart Failure in Atrial Fibrillation.

Authors:  Neal A Chatterjee; Claudia U Chae; Eunjung Kim; M Vinayaga Moorthy; David Conen; Roopinder K Sandhu; Nancy R Cook; I-Min Lee; Christine M Albert
Journal:  JACC Heart Fail       Date:  2017-06-14       Impact factor: 12.035

6.  Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure).

Authors:  Mark Richards; Salvatore Di Somma; Christian Mueller; Richard Nowak; W Frank Peacock; Piotr Ponikowski; Martin Mockel; Christopher Hogan; Alan H B Wu; Paul Clopton; Gerasimos S Filippatos; Inder Anand; Leong Ng; Lori B Daniels; Sean-Xavier Neath; Kevin Shah; Robert Christenson; Oliver Hartmann; Stefan D Anker; Alan Maisel
Journal:  JACC Heart Fail       Date:  2013-06-03       Impact factor: 12.035

Review 7.  Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins.

Authors:  Dipak Kotecha; Carolyn S P Lam; Dirk J Van Veldhuisen; Isabelle C Van Gelder; Adriaan A Voors; Michiel Rienstra
Journal:  J Am Coll Cardiol       Date:  2016-11-15       Impact factor: 24.094

Review 8.  Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes.

Authors:  Dipak Kotecha; Rajiv Chudasama; Deirdre A Lane; Paulus Kirchhof; Gregory Y H Lip
Journal:  Int J Cardiol       Date:  2015-10-28       Impact factor: 4.164

9.  Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction.

Authors:  Rajalakshmi Santhanakrishnan; Na Wang; Martin G Larson; Jared W Magnani; David D McManus; Steven A Lubitz; Patrick T Ellinor; Susan Cheng; Ramachandran S Vasan; Douglas S Lee; Thomas J Wang; Daniel Levy; Emelia J Benjamin; Jennifer E Ho
Journal:  Circulation       Date:  2016-01-08       Impact factor: 29.690

10.  Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire.

Authors:  John A Spertus; Philip G Jones
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-09
View more
  16 in total

1.  Atrial fibrillation in patients with systolic heart failure: pathophysiology mechanisms and management.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Nicholas Kounis; Grigorios Tsigkas
Journal:  J Geriatr Cardiol       Date:  2021-05-28       Impact factor: 3.327

2.  Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction.

Authors:  Charles D Nicoli; Wesley T O'Neal; Emily B Levitan; Matthew J Singleton; Suzanne E Judd; George Howard; Monika M Safford; Elsayed Z Soliman
Journal:  Heart       Date:  2021-05-24       Impact factor: 5.994

Review 3.  Research Priorities in Atrial Fibrillation Screening: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop.

Authors:  Emelia J Benjamin; Alan S Go; Patrice Desvigne-Nickens; Christopher D Anderson; Barbara Casadei; Lin Y Chen; Harry J G M Crijns; Ben Freedman; Mellanie True Hills; Jeff S Healey; Hooman Kamel; Dong-Yun Kim; Mark S Link; Renato D Lopes; Steven A Lubitz; David D McManus; Peter A Noseworthy; Marco V Perez; Jonathan P Piccini; Renate B Schnabel; Daniel E Singer; Robert G Tieleman; Mintu P Turakhia; Isabelle C Van Gelder; Lawton S Cooper; Sana M Al-Khatib
Journal:  Circulation       Date:  2021-01-25       Impact factor: 29.690

4.  Effect of Tricuspid Regurgitation on the Reported Quality of Life and Subsequent Outcomes in Patients With Atrial Fibrillation.

Authors:  Taishi Fujisawa; Takehiro Kimura; Nobuhiro Ikemura; Hiroshi Miyama; Yoshinori Katsumata; Ikuko Ueda; Kojiro Tanimoto; Hideaki Kanki; Keiichi Fukuda; Shun Kohsaka; Seiji Takatsuki
Journal:  J Am Heart Assoc       Date:  2022-04-06       Impact factor: 6.106

5.  Usefulness of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for predicting incident atrial fibrillation in heart failure with preserved ejection fraction patients.

Authors:  Yuzhong Wu; Zengshuo Xie; Weihao Liang; Ruicong Xue; Zexuan Wu; Dexi Wu; Jiangui He; Wengen Zhu; Chen Liu
Journal:  ESC Heart Fail       Date:  2021-01-27

6.  Aldosterone Antagonism in Atrial Fibrillation: Implications for AF-Predominant HFpEF.

Authors:  Jennifer E Ho
Journal:  J Am Heart Assoc       Date:  2020-09-10       Impact factor: 5.501

7.  Role of sacubitril-valsartan in the prevention of atrial fibrillation occurrence in patients with heart failure: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Xuehui Liu; Hongjun Liu; Lijun Wang; Lei Zhang; Qiang Xu
Journal:  PLoS One       Date:  2022-01-26       Impact factor: 3.240

8.  Quantifying the Impact of Atrial Fibrillation on Heart Failure-Related Patient-Reported Outcomes in the Utah mEVAL Program.

Authors:  Benjamin A Steinberg; Mingyuan Zhang; Jason Bensch; Ann Lyons; T Jared Bunch; Jonathan P Piccini; Alfonso Siu; John A Spertus; Josef Stehlik; Peter Wohlfahrt; Tom Greene; Rachel Hess; James C Fang
Journal:  J Card Fail       Date:  2021-07-26       Impact factor: 5.712

Review 9.  Natriuretic Peptide Clearance Receptor (NPR-C) Pathway as a Novel Therapeutic Target in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF).

Authors:  Emmanuel Eroume A Egom
Journal:  Front Physiol       Date:  2021-05-21       Impact factor: 4.566

10.  Association of heart failure subtypes and atrial fibrillation: Data from the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Miriam A M Nji; Scott D Solomon; Lin Yee Chen; Amil M Shah; Elsayed Z Soliman; Aniqa B Alam; Vinita Subramanya; Alvaro Alonso
Journal:  Int J Cardiol       Date:  2021-07-08       Impact factor: 4.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.